Description
Treatment options for Long Covid and Cognitive Dysfunction
Presenter by:
- Huzaifah Khan, Pharmacist
- Nicky Colyn, Nurse
- Ursula Shepherd, Pharmacist Assistant
Having practised through the pandemic, many prescribers were faced with considering new treatment modalities, with a substantial highlight on molecules in active ingredients that were not considered a part of the usual pharmaceutical options.
In the aftermath of the COVID Pandemic, more abstracts and research studies are being published on the effects of Long Covid and Cognitive Dysfunction.
Fagron invites you to a discussion on 3 molecules that have been studied, referenced and as proving very advantageous in treating patients with Long Covid, namely;
- β-Nicotinamide Adenine Dinucleotide (NAD+)
- Nicotinamide Riboside (in combination with Ginsenoside and methylcobalamin)
- Mitochondrin
